Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)
CUSIP: 03836J201
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Shares outstanding
- 9,144,889
- Total 13F shares
- 2,083,045
- Share change
- +458,641
- Total reported value
- $8,477,419
- Price per share
- $4.07
- Number of holders
- 27
- Value change
- +$1,866,030
- Number of buys
- 11
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 03836J201?
CUSIP 03836J201 identifies APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03836J201:
Top shareholders of APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AIGH Capital Management LLC |
13F
|
Company |
5.9%
|
539,300
|
$3,504,817 | — | 31 Mar 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
3%
|
276,603
|
$1,850,474 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
3%
|
270,000
|
$1,806,300 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.2%
|
205,760
|
$1,376,534 | — | 31 Mar 2024 | |
| Christian S. Schade |
3/4/5
|
Director |
—
mixed-class rows
|
312,846
mixed-class rows
|
$976,345 | — | 28 Jul 2022 | |
| DAFNA Capital Management LLC |
13F
|
Company |
1.5%
|
137,174
|
$917,694 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
115,978
|
$775,893 | — | 31 Mar 2024 | |
| Scott M. Coiante |
3/4/5
|
SVP, Chief Financial Officer |
—
mixed-class rows
|
234,265
mixed-class rows
|
$533,970 | — | 28 Jul 2022 | |
| Eyal C. Attar |
3/4/5
|
SVP, Chief Medical Officer, Director |
—
class O/S missing
|
57,392
|
$211,254 | — | 03 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.29%
|
26,818
|
$179,412 | — | 31 Mar 2024 | |
| Gregory Alan Korbel |
3/4/5
|
SVP, Chief Operating Officer |
—
mixed-class rows
|
81,462
mixed-class rows
|
$168,445 | — | 28 Jul 2022 | |
| Lars B. Abrahmsen |
3/4/5
|
SVP, Chief Scientific Officer |
—
mixed-class rows
|
143,700
mixed-class rows
|
$160,855 | — | 10 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
20,221
|
$135,321 | — | 31 Mar 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.15%
|
13,864
|
$93,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.09%
|
8,504
|
$56,891 | — | 31 Mar 2024 | |
| Nadeem Q. Mirza |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
33,650
mixed-class rows
|
$49,062 | — | 01 May 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.03%
|
2,570
|
$17,000 | — | 31 Mar 2024 | |
| Fouad Namouni |
3/4/5
|
Director |
—
mixed-class rows
|
27,360
mixed-class rows
|
$16,969 | — | 30 Jun 2021 | |
| Michael Aaron Kelly |
3/4/5
|
Director |
—
mixed-class rows
|
27,360
mixed-class rows
|
$16,969 | — | 30 Jun 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.02%
|
2,160
|
$14,450 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
1,566
|
$10,477 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,126
|
$7,533 | — | 31 Mar 2024 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.01%
|
1,000
|
$6,690 | — | 31 Mar 2024 | |
| NBC SECURITIES, INC. |
13F
|
Company |
0.01%
|
899
|
$6,000 | — | 31 Mar 2024 | |
| MB, LEVIS & ASSOCIATES, LLC |
13F
|
Company |
0.01%
|
806
|
$5,392 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
300
|
$2,007 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
272
|
$1,820 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
161
|
$1,077 | — | 31 Mar 2024 | |
| WealthCollab, LLC |
13F
|
Company |
0%
|
158
|
$1,058 | — | 31 Mar 2024 | |
| Princeton Global Asset Management LLC |
13F
|
Company |
0%
|
100
|
$669 | — | 31 Mar 2024 | |
| Towne Trust Company, N.A |
13F
|
Company |
0%
|
50
|
$335 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
3
|
$20 | — | 31 Mar 2024 |
Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q2 2024
As of 30 Jun 2024,
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,083,045 shares.
The largest 10 holders included
AIGH Capital Management LLC, Sio Capital Management, LLC, SPHERA FUNDS MANAGEMENT LTD., Nantahala Capital Management, LLC, Altium Capital Management LP, Exome Asset Management LLC, DAFNA Capital Management LLC, Stonepine Capital Management, LLC, VANGUARD GROUP INC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
22
Q2 2024 holders
27
Holder diff
5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.